The alarmin concept applied to human renal transplantation: Evidence for a differential implication of HMGB1 and IL-33

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Thierry, Antoine ^a,b   Giraud, Sébastien ^b,c   Robin, Aurélie ^b   Barra, Anne ^a,c,d   Bridoux, Franck ^a,c   Ameteau, Virginie ^b,c   Hauet, Thierry ^a,b,c   Girard, Jean Philippe ^e,f,g   Touchard, Guy ^a,b,c   Gombert, Jean Marc ^a,b,c   Herbelin, André ^b,c  

^a POITIERS UNIVERSITY HOSPITAL   (France)

^b Institut National de la Santé et de la Recherche Médicale U1082   (France)

^c UNIVERSITÉ DE POITIERS   (France)

^d Institut National de la Santé et de la Recherche Médicale U 1084   (France)

^e INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^f CNRS   (France)

^g UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 33; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; HMGB1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; COLD ISCHEMIA; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IN VITRO STUDY; INNATE IMMUNITY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; REOXYGENATION; REPERFUSION INJURY; UMBILICAL VEIN ENDOTHELIAL CELL; BLOOD; CELL HYPOXIA; FLOW CYTOMETRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; URINE;

ADULT; AGED; CELL HYPOXIA; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HMGB1 PROTEIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNITY, INNATE; INTERLEUKINS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; STATISTICS, NONPARAMETRIC;

EID: 84896757244     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088742     Document Type: Article

References (45)

1. Nankivell B, Chapman J (2006) Chronic Allograft Nephropathy: Current Concepts and Future Directions. Transplantation March 15, 2006 81: 643-654.
2. Eltzschig HK, Eckle T (2011) Ischemia and reperfusion-from mechanism to translation. Nature Medicine 17: 1391-1401.
3. Thurman JM (2007) Triggers of inflammation after renal ischemia/reperfusion. Clinical Immunology 123: 7-13.
4. Meier-Kriesche H, Schold JD, Srinivas TR, Kaplan B (2004) Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era. American Journal of Transplantation 4: 378-383. (Pubitemid 38282293)
5. Bon D, Chatauret N, Giraud S, Thuillier R, Favreau F, et al. (2012) New strategies to optimize kidney recovery and preservation in transplantation. Nature Reviews Nephrology 8: 339-347.
6. Rao DA, Pober JS (2008) Endothelial injury, alarmins, and allograft rejection. Crit Rev Immunol 28: 229-248.
7. Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Current Opinion in Immunology 13: 114-119. (Pubitemid 32096970)
8. Müller S, Ronfani L, Bianchi ME (2004) Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. Journal of Internal Medicine 255: 332-343. (Pubitemid 38315274)
9. Matsuoka N, Itoh T, Watarai H, Sekine-Kondo E, Nagata N, et al. (2010) High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. Journal of Clinical Investigation 120: 735-743.
10. Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, et al. (2007) HMGB1 release induced by liver ischemia involves Toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204: 2913-2923. (Pubitemid 350179560)
11. Li J, Gong Q, Zhong S, Wang L, Guo H, et al. (2011) Neutralization of the extracellular HMGB1 released by ischaemic-damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant 26: 469-478.
12. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, et al. (2010) HMGB1 Contributes to Kidney Ischemia Reperfusion Injury. Journal of the American Society of Nephrology 21: 1878-1890.
13. Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK (2007) Hypoxia Inducible Factor (HIF)-1 Coordinates Induction of Toll-Like Receptors TLR2 and TLR6 during Hypoxia. PLoS ONE 2: e1364.
14. Powers KA, Szászi K, Khadaroo RG, Tawadros PS, Marshall JC, et al. (2006) Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 203: 1951-1961. (Pubitemid 44188469)
15. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJD, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903. (Pubitemid 41434417)
16. Krüger B, Krick S, Dhillon N, Lerner SM, Ames S, et al. (2009) Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 106: 3390-3395.
17. Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, et al. (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A 104: 18660-18665. (Pubitemid 350210753)
18. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490. (Pubitemid 41587888)
19. Moussion C, Ortega N, Girard J-P (2008) The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel "Alarmin"? PLoS ONE 3: e3331.
20. Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Küchler AM (2009) Interleukin-33- cytokine of dual function or novel alarmin? Trends in Immunology 30: 227-233.
21. Akcay A, Nguyen Q, He Z, Turkmen K, Won Lee D, et al. (2011) IL-33 Exacerbates Acute Kidney Injury. Journal of the American Society of Nephrology 22: 2057-2067.
22. Bao Y-S, Na S-P, Zhang P, Jia X-B, Liu R-C, et al. (2012) Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease. J Clin Immunol 32: 587-594.
23. Sakai N, Van Sweringen HL, Quillin RC, Schuster R, Blanchard J, et al. (2012) Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology: 56 (4).
24. Wagenaar JFP, Gasem MH, Goris MGA, Leeflang M, Hartskeerl RA, et al. (2009) Soluble ST2 Levels Are Associated with Bleeding in Patients with Severe Leptospirosis. PLoS Neglected Tropical Diseases 3: e453.
25. Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie ANJ, et al. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117: 1538-1549. (Pubitemid 46871338)
26. Rabadi MM, Kuo M-C, Ghaly T, Rabadi SM, Weber M, et al. (2012) Interaction between uric acid and HMGB1 translocation and release from endothelial cells. American Journal of Physiology - Renal Physiology 302: F730-F741.
27. Mullins GE, Sunden-Cullberg J, Johansson A-S, Rouhiainen A, Erlandsson-Harris H, et al. (2004) Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High-Mobility Group Box Chromosomal Protein 1. Scandinavian Journal of Immunology 60: 566-573. (Pubitemid 39665101)
28. Li L, Huang L, Sung SJ, Lobo PI, Brown MG, et al. (2007) NKT Cell Activation Mediates Neutrophil IFN-γ Production and Renal Ischemia-Reperfusion Injury. The Journal of Immunology 178: 5899-5911. (Pubitemid 46674387)
29. Bourgeois E, Van LP, Samson M, Diem S, Barra A, et al. (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. European Journal of Immunology 39: 1046-1055.
30. Smithgall MD, Comeau MR, Park Yoon B-R, Kaufman D, Armitage R, et al. (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells. International Immunology 20: 1019-1030.
31. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, et al. (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine 13: 1050-1059. (Pubitemid 47517504)
32. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, et al. (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. PNAS 107: 18581-18586.
33. Bourgeois EA, Levescot A, Diem S, Chauvineau A, Bergès H, et al. (2011) A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation. European Journal of Immunology 41: 299-305.
34. Wolfs TGAM, Buurman WA, Schadewijk A van, Vries B de, Daemen MARC, et al. (2002) In Vivo Expression of Toll-Like Receptor 2 and 4 by Renal Epithelial Cells: IFN-γ and TNF-α Mediated Up-Regulation During Inflammation. J Immunol 168: 1286-1293. (Pubitemid 34094497)
35. Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, et al. (2011) Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney International 79: 288-299.
36. Krüger B, Yin N, Zhang N, Yadav A, Coward W, et al. (2010) Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. European Journal of Immunology 40: 2914-2924.
37. Fagundes CT, Amaral FA, Souza ALS, Vieira AT, Xu D, et al. (2007) ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol 81: 492-499. (Pubitemid 46198401)
38. Mirchandani AS, Salmond RJ, Liew FY (2012) Interleukin-33 and the function of innate lymphoid cells. Trends in Immunology 33: 389-396.
39. Liu A, Jin H, Dirsch O, Deng M, Huang H, et al. (2010) Release of Danger Signals during Ischemic Storage of the Liver: A Potential Marker of Organ Damage? Mediators of Inflammation 2010: 1-11.
40. Goffic RL, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, et al. (2011) Infection with Influenza Virus Induces IL-33 in Murine Lungs. Am J Respir Cell Mol Biol 45: 1125-1132.
41. Matsuyama Y, Okazaki H, Hoshino M, Onishi S, Kamata Y, et al. (2012) Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response. Rheumatol Int 32: 1397-1401.
42. Salahudeen AK, Haider N, May W (2004) Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney International 65: 713-718. (Pubitemid 38130670)
43. Yin H, Li X-Y, Jin X-B, Zhang B-B, Gong Q, et al. (2010) IL-33 Prolongs Murine Cardiac Allograft Survival Through Induction of TH2-Type Immune Deviation. Transplantation 89: 1189-1197.
44. Brunner SM, Schiechl G, Falk W, Schlitt HJ, Geissler EK, et al. (2011) Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transplant International 24: 1027-1039.
45. Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, et al. (2011) IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells (Treg), including ST2L+ Foxp3+ cells, and mediates Treg-dependent promotion of cardiac allograft survival. J Immunol 187: 4598-4610.